Marker Therapeutics, Inc. — Director's Dealing 2018

Nov 29, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Marker Therapeutics, Inc. (MRKR)
CIK: 0001094038
Period of Report: 2018-11-27

Reporting Person: Kim Anthony H. (Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-11-27	Employee Stock Option (Right to Buy)	$6.81	A	400000	Acquired	2028-11-27	Common Stock (400000)	Direct

Footnotes

F1: Represents options granted under the Company's 2014 Omnibus Stock Ownership Plan, as amended, in connection with the execution of an employment agreement with the Company. One quarter of the shares vest on the first anniversary of the grant date and the remainder of the shares subsequently vest in equal monthly installments over a three year period upon the continued employment by the Company of the Reporting Person through the vesting dates. The option exercise price is the closing price on the date of the grant, November 27, 2018.